These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 583004)

  • 1. [Metabolism of antipsoriatic anthrone derivatives].
    Wiegrebe W; Gerber A; Kappler J; Bayerl C
    Arzneimittelforschung; 1979; 29(8):1083-8. PubMed ID: 583004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure specificity of the antipsoriatic anthrones.
    Krebs A; Schaltegger H; Schaltegger A
    Br J Dermatol; 1981 Aug; 105 Suppl 20():6-11. PubMed ID: 7284267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dermal absorption and metabolism of the antipsoriatic drug dithranol triacetate.
    Wiegrebe W; Retzow A; Plumier E; Ersoy N; Garbe A; Faro HP; Kunert R
    Arzneimittelforschung; 1984; 34(1):48-51. PubMed ID: 6538420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-activity relationships for the formation of secondary radicals and inhibition of keratinocyte proliferation by 9-anthrones.
    Hayden PJ; Free KE; Chignell CF
    Mol Pharmacol; 1994 Jul; 46(1):186-98. PubMed ID: 8058052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of psoriasis with anthrones-chemical principles, biochemical aspects, and approaches to the design of novel derivatives.
    Wiegrebe W; Müller K
    Skin Pharmacol; 1995; 8(1-2):1-24. PubMed ID: 7786521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure and tumor-promoting activity of analogues of anthralin (1,8-dihydroxy-9-anthrone).
    Van Duuren BL; Segal A; Tseng SS; Rusch GM; Loewengart G; Maté U; Roth D; Smith A; Melchionne S; Seidman I
    J Med Chem; 1978 Jan; 21(1):26-31. PubMed ID: 619147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antipsoriatic drug action of anthralin: oxidation reactions with peroxidizing lipids.
    Ducret F; Lambelet P; Löliger J; Savoy MC
    J Free Radic Biol Med; 1985; 1(4):301-6. PubMed ID: 3836247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of skin tumor promotion and progression by chrysarobin in SENCAR mice.
    Kruszewski FH; Conti CJ; DiGiovanni J
    Cancer Res; 1987 Jul; 47(14):3783-90. PubMed ID: 3109733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Substitution of Hydrogen Atoms in the Molecules of Anthrone and Anthraquinone.
    Szymańska M; Majerz I
    Molecules; 2021 Jan; 26(2):. PubMed ID: 33477805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic activation of sennoside C in mice: synergistic action of anthrones.
    Yamauchi K; Shinano K; Nakajima K; Yagi T; Kuwano S
    J Pharm Pharmacol; 1992 Dec; 44(12):973-6. PubMed ID: 1361561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antipsoriatic activity of 10-acyl analogues of dithranol (anthralin). I. Phase I clinical trial of 10-propionyl dithranol and 10-butyryl dithranol (butantrone).
    Mustakallio KK; Brandt H
    Acta Derm Venereol; 1984; 64(1):63-6. PubMed ID: 6203285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The metabolism of anthranoid laxatives.
    de Witte P; Lemli L
    Hepatogastroenterology; 1990 Dec; 37(6):601-5. PubMed ID: 2289777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An EPR study of free radicals formed by antipsoriatic and tumor-promoting 9-anthrones in nonpolar solvents.
    Motten AG; Sik RH; Chignell CF; Hayden PJ
    Chem Res Toxicol; 1994; 7(6):877-81. PubMed ID: 7696546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Triacetoxyanthracene--a new drug in the treatment of psoriasis].
    Fredriksson T; Nordin-Björklund K
    Lakartidningen; 1970 Apr; 67(16):1813-5. PubMed ID: 5434095
    [No Abstract]   [Full Text] [Related]  

  • 15. Detection and characterization of 9-anthron-10-yl radicals formed by antipsoriatic and tumor-promoting 9-anthrones in aqueous buffers.
    Hayden PJ; Chignell CF
    Chem Res Toxicol; 1993; 6(2):231-7. PubMed ID: 8386561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro reduction of rhein anthraquinone to rhein anthrone by rat cecal microflora and some intestinal bacterial strains.
    de Witte P; Van Hoestenberghe A; Eyssen H
    Biopharm Drug Dispos; 1992 May; 13(4):243-53. PubMed ID: 1600110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies in the field of drugs containing anthracene derivatives.
    Verhaeren EH; Dreessen M; Lemli J
    Planta Med; 1982 May; 45(5):15-9. PubMed ID: 17396771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The treatment of psoriasis with triacetoxyanthracene.
    Whitefield M
    Arzneimittelforschung; 1970 Jan; 20(1):137-9. PubMed ID: 5467436
    [No Abstract]   [Full Text] [Related]  

  • 19. Metabolism and pharmacokinetics of anthranoids.
    de Witte P
    Pharmacology; 1993 Oct; 47 Suppl 1():86-97. PubMed ID: 8234447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antipsoriatic anthrones with modulated redox properties. 4. Synthesis and biological activity of novel 9,10-dihydro-1,8-dihydroxy-9-oxo-2-anthracenecarboxylic and -hydroxamic acids.
    Müller K; Prinz H
    J Med Chem; 1997 Aug; 40(17):2780-7. PubMed ID: 9276024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.